Galmed Pharmaceuticals Ltd Net Asset Quality Index
Galmed Pharmaceuticals Ltd net asset quality index. Galmed Pharmaceuticals Ltd (GLMD) has a Net Asset Quality Index of 69.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $18.28 Million minus total liabilities of $5.54 Million yields net assets of $12.74 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Galmed Pharmaceuticals Ltd net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Galmed Pharmaceuticals Ltd (2012–2025)
Net asset quality index of Galmed Pharmaceuticals Ltd from 2012 to 2025. This chart shows how Galmed Pharmaceuticals Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 69.7%, representing net assets of $12.74 Million against total assets of $18.28 Million USD. Check Galmed Pharmaceuticals Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Galmed Pharmaceuticals Ltd Net Asset Quality Index by Year (2012–2025)
Galmed Pharmaceuticals Ltd net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Galmed Pharmaceuticals Ltd from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Galmed Pharmaceuticals Ltd.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.7% | $15.78 Million | $18.63 Million | $2.85 Million | ▼ -3.5 pp |
| 2024 | 88.3% | $16.33 Million | $18.50 Million | $2.17 Million | ▲ +4.8 pp |
| 2023 | 83.5% | $13.88 Million | $16.63 Million | $2.75 Million | ▲ +2.4 pp |
| 2022 | 81.1% | $13.42 Million | $16.56 Million | $3.14 Million | ▼ -2.3 pp |
| 2021 | 83.3% | $30.50 Million | $36.60 Million | $6.11 Million | ▼ -1.0 pp |
| 2020 | 84.3% | $44.15 Million | $52.38 Million | $8.23 Million | ▼ -6.3 pp |
| 2019 | 90.6% | $69.85 Million | $77.14 Million | $7.29 Million | ▼ -6.5 pp |
| 2018 | 97.0% | $87.89 Million | $90.60 Million | $2.71 Million | ▲ +16.6 pp |
| 2017 | 80.4% | $15.79 Million | $19.64 Million | $3.85 Million | ▲ +13.1 pp |
| 2016 | 67.3% | $11.07 Million | $16.45 Million | $5.38 Million | ▼ -21.5 pp |
| 2015 | 88.8% | $21.55 Million | $24.26 Million | $2.72 Million | ▼ -6.6 pp |
| 2014 | 95.4% | $31.41 Million | $32.92 Million | $1.52 Million | ▲ +1270.7 pp |
| 2013 | -1175.3% | $-1.95 Million | $166.00K | $2.12 Million | ▼ -915.6 pp |
| 2012 | -259.7% | $-1.98 Million | $762.00K | $2.74 Million | — |